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Abstract
Cell heterogeneity and the inherent complexity due to the interplay of multiple molecular processes within the cell pose
difficult challenges for current single-cell biology. We introduce an approach that identifies a disease phenotype from
multiparameter single-cell measurements, which is based on the concept of ‘‘supercell statistics’’, a single-cell-based
averaging procedure followed by a machine learning classification scheme. We are able to assess the optimal tradeoff
between the number of single cells averaged and the number of measurements needed to capture phenotypic differences
between healthy and diseased patients, as well as between different diseases that are difficult to diagnose otherwise. We
apply our approach to two kinds of single-cell datasets, addressing the diagnosis of a premature aging disorder using
images of cell nuclei, as well as the phenotypes of two non-infectious uveitides (the ocular manifestations of Behc¸et’s
disease and sarcoidosis) based on multicolor flow cytometry. In the former case, one nuclear shape measurement taken
over a group of 30 cells is sufficient to classify samples as healthy or diseased, in agreement with usual laboratory practice.
In the latter, our method is able to identify a minimal set of 5 markers that accurately predict Behc¸et’s disease and
sarcoidosis. This is the first time that a quantitative phenotypic distinction between these two diseases has been achieved.
To obtain this clear phenotypic signature, about one hundred CD8+ T cells need to be measured. Although the molecular
markers identified have been reported to be important players in autoimmune disorders, this is the first report pointing out
that CD8+ T cells can be used to distinguish two systemic inflammatory diseases. Beyond these specific cases, the approach
proposed here is applicable to datasets generated by other kinds of state-of-the-art and forthcoming single-cell
technologies, such as multidimensional mass cytometry, single-cell gene expression, and single-cell full genome sequencing
techniques.
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Introduction
In the life sciences, there is now a wealth of quantitative
information from simultaneous measurements on many proteins
and genes, from small tissue samples down to a single cell at a time
[1–6]. Likewise, bioimaging is following a similar trend through
multicolor fluorescent imaging and the emerging ability to carry
out spatially resolved vibrational spectroscopy of living cells in
close to real-time [7,8]. These groundbreaking technologies have
resulted in a plethora of information for single cells, which can be
represented as points in a high-dimensional space. Here we show
how one can tease out the essential information from such high-
dimensional data in order to diagnose human diseases and
understand their molecular origins.
Our approach tackles two interlinked challenges inherent to high-
dimensional, single-cell information. First, single-cell measurements
exhibit vast heterogeneity in the behavior of individual cells: even a
simple bell-shaped distribution can contain subpopulations enriched
for biologically distinct functions. For instance, subpopulations of
clonally derived hematopoietic progenitor cells with low or high
expression of the stem cell marker Sca-1 were observed to be in
dramatically different transcriptional states and to give rise to
different blood cell lineages [9]. Second, cell phenotypes are
emergent products of multiple molecular actions: the phenotype of a
tissue or organism often requires not only multiple cells, but also
multiple attributes at the cellular level, which makes bridging scales
from molecular and cellular level information to disease diagnosis a
challenging, oftentimes elusive goal [10].
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Here we present a new approach to analyze high-dimensional
single-cell information, and apply it to two representative datasets.
We address the diagnosis of progeria, a premature aging disorder
[11], where single-cell data are obtained by an automated nuclear
shape analysis from hundreds of healthy and diseased cells. We
also develop a multiparameter phenotype in order to distinguish
two sight threatening non-infectious uveitides, the ocular mani-
festations of Behc¸et’s disease and sarcoidosis, based on multicolor
flow cytometry information on tens of proteins from fresh blood
patient samples. Our emphasis is to assess the optimal tradeoff
between the number of single cells averaged and the number of
measurements needed to capture phenotypic difference. The
number of available cells may be a key limiting factor when target
cell subpopulations are extremely small (e.g. hematopoietic stem
cells from bone marrow or blood samples) or when the
experimental techniques are not easily scalable (e.g. single-cell
imaging and single-cell gene expression).
In the next Section, we describe some common approaches to
analyze multidimensional single-cell datasets, we show their
shortcomings due to cell heterogeneity and the inherent multidi-
mensional nature implied in a complex phenotype, and we apply
our approach to the two specific cases mentioned above. In the
following Section, we provide a summary and a discussion of our
findings.
Results
A commonly used method to visualize and analyze multidi-
mensional single cell information is through sequential selection of
subtypes of cells based on simple thresholds, applied to one or two
parameters at a time [12]. This procedure is generally represented
as a sequence of two-dimensional plots, where one attribute is
plotted against another one. This method works extremely well
when simple thresholds for just a few parameters lead to reliable
phenotypes. However, for complex diseases such as Behc¸et’s and
sarcoidosis, even the best choice of parameters is not enough to
identify a phenotype. A representative example is shown in
Fig. 1A(i): CD8+ T cells have very similar combinations of IL22
and CD3 levels in both Behc¸et’s disease and sarcoidosis, even
though – as we will show below – these parameters play a key role
in distinguishing between the two diseases. Similarly, highly
overlapping populations are observed for other cell types we
investigated (e.g. CD4+ T cells) and other pairs of markers studied.
This indicates that the distinction between Behc¸et’s disease and
sarcoidosis can only be discerned using a combination of more
than two parameters, and thus is difficult to visualize and detect
with established approaches.
Going beyond two parameters, some mathematical tools are
able to reduce the dimensionality of high-dimensional data
[13,14]. Singular value decomposition is a simple, yet powerful
technique for generating low dimensional representations [13].
However, the optimal axes selected by such a method are not
designed to distinguish between health and disease, or help
diagnose the disease. This is evident in Fig. 1A(ii), where the two
top eigenmodes from a singular-value decomposition analysis of
16-dimensional data are plotted for the same CD8+ T cell
subpopulation, showing again a large overlap between the two
diseases.
Even in cases where a single parameter can be established as a
suitable phenotype, cell-to-cell heterogeneity presents a challenge.
For example, in Hutchinson-Gilford progeria syndrome (HGPS), a
rare genetic disease of accelerated aging, the number of ‘‘blebs’’ or
localized protrusions visible in a cell’s nucleus is an established
cellular marker of HGPS [15]. However, that does not imply that
a single cell showing blebs indicates HGPS. Instead, as shown by
Fig. 1B(i)–(iv), blebbed and non-blebbed nuclei are observed both
within healthy and diseased cell lines. On average, nevertheless,
blebbing is a reliable phenotype, as illustrated in Fig. 1B(v)–(vi).
This raises the question: can one simply measure other aspects of
the nuclear shape with additional metrics to establish a disease
phenotype from a single cell, or does cell heterogeneity require us
to investigate the properties of cell ensembles for a reliable
diagnosis? The tradeoff between multidimensional measurements
and the number of cells needed to achieve a desired confidence
level of prediction certainly requires an unbiased, fully quantita-
tive, and mathematically robust method.
Here we introduce and apply an approach to develop a disease
phenotype from multiparameter single-cell measurements. Our
approach uses simple machine learning methods to determine
what combination of parameters can serve as an indicator of
disease, and how many parameters are needed to diagnose a
disease. While machine learning of disease diagnostics is not new,
it often fails when applied at the single-cell level due to the
heterogeneity of cells. It also fails when average quantities are
measured if the number of patients is not large enough for a
machine learning approach. The simple additional step of
averaging over a small number of cells - here tens to hundreds
of cells – and varying that number allows us to optimize our ability
to detect a disease phenotype. This procedure smoothes out single
cell heterogeneity and, at the same time, minimizes the loss of
information due to averaging. For machine learning purposes,
each patient is still represented by a point cloud in parameter
space, but now each point represents a group of cells, rather than
an individual cell.
Recently, several groups have developed computational meth-
ods for identifying cell populations in multidimensional flow
cytometry data. Their goals are two-fold: on the one hand, to
determine whether automated algorithms can reproduce expert
manual gating; on the other hand, to determine whether analysis
pipelines can identify characteristics that correlate with external
variables such as clinical outcome. In the latter case, flow
cytometry data is transformed into class-labeled vectors in instance
space by a variety of methods such as binning of 2D and 3D
measurement histograms, Gaussian mixtures, 1D and sequential
Author Summary
The behavior of organisms is based on the concerted
action occurring on an astonishing range of scales from
the molecular to the organismal level. Molecular properties
control the function of a cell, while cell ensembles form
tissues and organs, which work together as an organism. In
order to understand and characterize the molecular nature
of the emergent properties of a cell, it is essential that
multiple components of the cell are measured simulta-
neously in the same cell. Similarly, multiple cells must be
measured in order to understand health and disease in the
organism. In this work, we develop an approach that is
able to determine how many cells, how many measure-
ments per cell, and which measurements are needed to
reliably diagnose disease. We apply this method to two
different problems: the diagnosis of a premature aging
disorder using images of cell nuclei, and the distinction
between two similar autoimmune eye diseases using
stained cells from patients’ blood samples. Our findings
shed new light on the role of specific kinds of immune
system cells in systemic inflammatory diseases and may
lead to improved diagnosis and treatment.
From Cellular Characteristics to Disease Diagnosis
PLOS Computational Biology | www.ploscompbiol.org 2 September 2013 | Volume 9 | Issue 9 | e1003215
gating schemes, and cell clustering using k-means and other high-
dimensional clustering techniques [16–23]. A detailed description
and comparative assessment of the performance of different
approaches has been recently reported [24]. Within this context, it
is important to point out that the method proposed in our work
addresses the problem of phenotypic classification when single cells
are highly heterogeneous and when the number of cells available
may be rather small (just a few tens or hundreds, as opposed to
typical flow cytometry experiments in which the number of
measured cells is one or several orders of magnitude larger). We
will demonstrate that our method is generally applicable to
different kinds of multidimensional single-cell data and one of our
examples is on flow- cytometry-based phenotypes. However, the
key contribution is the development of a framework that provides
a quantitative assessment of the critical sample size and number of
simultaneous single-cell measurements needed to identify a
phenotype with strong predictive power. State-of-the-art single-
cell genomics and single-cell imaging technologies are examples in
which the number of measured single cells is critically small, and
where flow cytometry data analysis methods that rely on high-
dimensional clustering procedures, Gaussian mixture approxima-
tions, etc may be expected to fail.
We will tackle the tradeoff between the number of parameters
and the number of cells needed first on the example of HGPS - the
mathematics are the same for any multidimensional single-cell
dataset. A complete approach would entail the study of the
distribution of the individual measurement vectors. Our results
demonstrate, a posteriori, that simple averages suffice for carrying
out the calculations successfully. We define a ‘‘supercell of size N’’
as the average of the individual measurement vectors of N
randomly selected cells. By repeatedly taking different random
subsets of N cells from the original datasets, we build ‘‘supercell
samples’’ and we are thus able to compute ‘‘supercell statistics’’.
This procedure is illustrated in Fig. 2A(i)–(ii), where we select one
shape parameter (namely, the number of invaginations of the
nuclear boundary) and compute the probability density distribu-
tions for healthy and diseased cell lines. In Fig. 2A(i), the
distributions for single cells are highly overlapping, reflecting the
fact that, based on individual cells, one is not able to distinguish
healthy cells from diseased ones (Dataset S1). After applying the
cell averaging procedure (using N=30 randomly selected cells to
generate each ‘‘supercell’’), we obtain distributions without any
significant overlap between healthy and diseased samples, as
shown by Fig. 2A(ii). The supercell size N= 30 has been chosen
Figure 1. Identifying diseases from heterogeneous single cells. A. Using standard methods of flow cytometry analysis, diseases such as
sarcoidosis and Behc¸et’s cannot be separated. (i) 2D scatter plot using markers CD3 and IL22. (ii) 2D Singular-Value decomposition analysis. Figs. A(i)–
(ii) show CD8+ T cell subsamples from a cohort of 7 sarcoidosis patients and 6 patients diagnosed with Behc¸et’s disease, but similar overlaps are also
observed for other cell types and marker pairs. B. Cell ensembles carry the signatures of health and disease, despite heterogeneity at the single-cell
level. (i)–(iv) Nuclear shapes of healthy and diseased (HGPS) cells can be classified as either blebbed or non-blebbed. Scale bar: 10 m. Note that it is
impossible to tell whether a person has the disease or not based on the analysis of a single cell. (v) Classifying nuclei as blebbed (red) or non-blebbed
(black) based on just one shape parameter, which is automatically determined via custom image analysis software. Most cells in the ensemble of 30
randomly selected nuclei from a diseased cell line are labeled as blebbed. Scale bar: 50 m. (vi) Conversely, analyzing nuclei from a healthy cell line,
most cells are labeled as non-blebbed.
doi:10.1371/journal.pcbi.1003215.g001
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because it represents the smallest size that provides a full
separation between healthy and diseased samples, regardless of
the number of parameters used (see discussion below).
The removal of distribution overlaps is a manifestation of the
central limit theorem (CLT) of probability theory [25–27]. The
CLT states that, given a set of n independent random variables
associated with arbitrary probability distributions with finite mean
mi and variance si
2 (for i = 1,2,…,n), their average is a random
variable whose asymptotic cumulative distribution function
approaches a normal distribution with mean m=gmi/n and
variance s2 = (gsi
2/n)/n. As a consequence, distributions of
supercells of size N are expected to become narrower by a factor of
,1/!N. For instance, comparing Fig. 2A(i) with Fig. 2A(ii), we
observe that the width of the latter is approximately smaller by a
factor of ,1/!30<0.2. Another consequence of the CLT is that
the shape of supercell distributions becomes closer to Gaussian as
N is increased. It should be pointed out that the supercell
framework does not rely on a priori assumptions regarding the
shape of the measurement distributions. On the contrary, it
incorporates all features of the original distributions, thus naturally
dealing with issues such as skewed distributions with regions that
could be ambiguously attributed to outliers or to poorly resolved
subpopulations. However, if the measurement distributions are
distinctly multimodal due to well-defined cell subpopulations, then
the ability to predict reliable phenotypes might be compromised.
In such a scenario, robust phenotyping might first require the
identification of different cell subpopulations followed by the
application of the supercell framework separately to each of them.
This procedure is discussed below in the context of distinguishing
healthy individuals from patients with two non-infectious uveitides
by using either all cells from peripheral blood samples, or different
T cell subpopulations (see Fig. 3).
After cell averaging, machine learning allows us to learn what
combination of parameters best distinguishes healthy from
diseased cells. In order to avoid overfitting and also to obtain a
straightforward interpretation of the machine-learned parameters
in terms of the original measurements, we used a support vector
machine with a linear kernel, which is equivalent to the machine
Figure 2. Quantitative multiparameter phenotyping of healthy and HGPS cells through cell averaging (‘‘supercells’’) and machine
learning. A. Probability density distributions for one shape parameter (number of invaginations of the nuclear boundary) for healthy and diseased
cell lines: (i) single cells; (ii) supercells of size 30. The cell averaging procedure removes the overlap between healthy and diseased cell line
distributions. B. Distance from the perceptron boundary after machine learning, where positive (negative) distances correspond to the boundary side
identified with the healthy (diseased) class: (i) single cells; (ii) supercells of size 30. Each cell line is shown separately along the horizontal axis. C. (i)
Perceptron amplitudes: components of the vector normal to the classification hyperplane, each one associated with one of the shape parameters
shown in the list. (ii) Fraction of cells correctly classified by the machine learning process as a function of the supercell size for a varying number of
parameters used, as indicated. The top M measures are selected from the rank-ordered list based on the absolute values of the perceptron
amplitudes.
doi:10.1371/journal.pcbi.1003215.g002
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learning method known as the perceptron [28,29]. Healthy and
HGPS nuclear shapes were characterized by 12 parameters
including eccentricity, number of invaginations, minor/major axis
length, mean and standard deviation of the curvature, and
perimeter. Moreover, the concentration of lamin A/C (measured
based on the fluorescence signals of lamin A/C) was represented
through 3 additional parameters for each nucleus. However, for
single cells, even with these 15 parameters, the distinction between
individual cells from healthy and diseased cell lines is not
learnable. Fig. 2B(i) shows the distance from each cell to the
perceptron boundary, where positive (negative) distances corre-
spond to the boundary side identified with the healthy (diseased)
class. We observe that some cells from the healthy cell lines are
classified as diseased, and vice versa. Instead, machine learning
applied to the supercell samples works with 100% accuracy, as
displayed in Fig. 2B(ii).
The questions arise, then, which and how many parameters are
needed to achieve a classification of desired accuracy, and how
many cells need to be averaged into a ‘‘supercell’’. Fig. 2C(i) shows
the perceptron amplitudes (i.e., the components of the vector
normal to the boundary hyperplane) for each of the 15
parameters. A positive sign indicates that a given parameter is
higher in healthy cells relative to diseased cells, while its absolute
value is a measure of its overall significance (relative to the other
parameters) in separating healthy cells from diseased ones.
Therefore, we can rank-order the 15 parameters from most to
least relevant according to their decreasing amplitudes (in absolute
values), and learn using just the top M parameters from the rank-
ordered list. While this rank ordering is independent of supercell
size for large supercells, it it is very different from the rank
ordering for single cells (if the single cell measurements are
strongly overlapping). Indeed, sizable fluctuations are observed in
the single-cell and small-supercell regime (up to supercells of size
,10) followed by a stable rank-order for larger supercell sizes. The
fraction of cells correctly classified by the machine learning process
as a function of the supercell size is shown in Fig. 2C(ii). The
Figure 3. Predictive power of automated phenotyping to distinguish healthy vs diseased, or sarcoidosis vs Behc¸et’s for different
cell types and number of markers measured. (a)–(f) A jackknife analysis of patient classification was carried out based on a sample with 100
supercells, where each supercell was obtained from averages over 500 randomly chosen cells. The percentage of patients correctly classified is shown
as green bars, the percentage of patients for which a classification is not possible (because less than 95% of supercells fall into either one of the
classes) is shown as blue bars, while the percentage of patients incorrectly classified is shown as red bars. The top 10 measures for each case are listed
to the right of each plot. Separate analyses have been carried out for all cells, CD4+ T cells and CD8+ T cells, as indicated, as well as for the two binary
classification scenarios ‘‘healthy vs diseased’’, and ‘‘sarcoidosis vs Behc¸et’s’’. (g) Percentage of supercells correctly classified as healthy or diseased, as a
function of the supercell size and the number of measures used, within the CD4+ T cell subpopulation. (h) Distribution of the top marker (CD27) for
supercells averaged over 500 randomly chosen CD4+ T cells. (i) Percentage of supercells correctly classified as sarcoidosis or Behc¸et’s disease, as a
function of the supercell size and the number of measures used, within the CD8+ T cell subpopulation. (j) Linear combination of the top 5 markers
IL22, CD3, viability, CD8 and CD62L, as a function of CD3, for supercells averaged over 500 randomly chosen CD8+ T cells.
doi:10.1371/journal.pcbi.1003215.g003
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different curves represent different numbers of parameters (M). As
expected, the classification accuracy increases with both M and the
supercell size. While a single cell is not sufficient for classification, a
single parameter (the number of invaginations) is sufficient for
correct classification of HGPS. Indeed, this is consistent with the
standard approach to assess the disease states of HGPS based on
visual analysis (i.e. the detection of ‘‘blebs’’) and indicates that the
invaginations are the most distinguishing features of blebs [30–32].
In our second example, we apply our technique first to the
simpler problem of distinguishing healthy individuals from patients
with two non-infectious uveitides, and then to the formidable
challenge of distinguishing Behc¸et’s disease from sarcoidosis. Recent
work has reported progress in the ability to pinpoint molecular
indicators for inflammatory immune diseases, where larger-than-
normal levels of a novel subset of effector memory CD4+ T
lymphocytes expressing the endothelial adhesion molecule CD146
have been observed in sarcoidosis, Behc¸et’s, and Crohn’s disease
[33]. However, while patients can be diagnosed with Behc¸et’s
disease or sarcoidosis based on the concurrent observation of a
number of clinical indicators, molecular signatures unique to these
diseases have not been found. Our analysis of a molecular
phenotype uses flow cytometry experiments, in which 14 molecular
markers previously reported on human CD4+ and/or CD8+ T cells
were measured for each cell; additionally, forward- (FSC) and side-
scattering (SSC) measures were also taken on each cell. Thus, a total
of 16 simultaneous measurements were performed on each cell from
patients’ peripheral blood, with about one million cells measured
per patient. From a cohort of 22 patients, 7 were diagnosed with
sarcoidosis, 6 with Behc¸et’s disease, 1 with retinal vasculitis, while
the remaining 8 were healthy controls. We start with large supercells
to assess whether molecular phenotyping is possible at all to
distinguish sarcoidosis and Behc¸et’s disease. We represent each
patient sample with 100 supercells, where each supercell was
obtained from averages over 500 randomly chosen cells. We carry
out separate analyses for the distinction between healthy and
diseased patients (Fig. 3(a)–(c)), and for the separation between the
two diseases sarcoidosis and Behc¸et’s (Fig. 3(d)–(f)). Furthermore, we
perform separate analyses for all cells (Dataset S2), for CD4+ T cells
(that can be isolated using standard gating procedures based on the
sequence viability2/CD3+/CD4+/CD82) (Dataset S3) and for
CD8+ T cells (similarly identified according to viability2/CD3+/
CD8+/CD42) (Dataset S4).
Because we have a larger number of patients than we did for
HGPS, we can directly assess the predictive power of our
approach to correctly diagnose a new patient. We tested the
predictive power of our learnt patterns using a standard data-
resampling method, namely the so-called jackknife procedure:
leaving out one patient at a time, one learns with the remaining
data and makes a prediction on the test patient [34]. In that way,
one can determine the percentage of correct and failed predic-
tions. Since each patient is represented by a cloud of 100
supercells, it may happen that the perceptron boundary cuts across
the test patient’s supercell cloud. We set a threshold of 95% in
order to make a prediction: e.g. if the supercell cloud is more than
95% consistent with sarcoidosis, we classify the patient as having
sarcoidosis. If the supercell cloud falls on the boundary between
diagnoses (i.e. with less that 95% of the supercells on either side of
the perceptron boundary), we leave the test patient unclassified.
Naturally, setting the prediction threshold to lower values leads to
less unclassified patients, but tends to increase the number of failed
predictions; in contrast, increasing the threshold to higher values
leads to a more conservative approach, where the number of failed
predictions is smaller at the expense of a larger number of
unclassified patients. By changing the prediction threshold values
over the range between 80% and 100%, the observed variations of
the predicted outcome were below 10% of the cohort; the method
is thus largely insensitive to the choice of the threshold parameter.
By learning using all available measures, we are able to rank-
order the importance of the measures based on the perceptron
amplitudes. The ten most important measures and corresponding
amplitudes are listed in Fig. 3(a)–(f). The percentage of patients
correctly predicted (green), unclassified (blue), and incorrectly
predicted (red) are shown as a function of the number of rank-
ordered measures used. The outcomes depend strongly on the type
of cells used: for the ‘‘healthy vs diseased’’ case, no incorrect
predictions are made using all cells and just the top two measures,
namely viability and CD197 (Fig. 3(a)). The predictions are even
stronger if using only CD4+ T cells, since the top marker (CD27) is
sufficient by itself to correctly classify all healthy patients (with high
frequency of CD4+CD27+ T cells in their peripheral blood) and all
diseased patients (with low frequency of CD4+CD27+ T cells in
their peripheral blood) in the cohort (Fig. 3(b)). In contrast, failed
predictions are seen for the case of CD8+ T cells, irrespective of
the number of measures used (Fig. 3(c)). Previous reports have
suggested that CD4+CD27+ T cells represent the majority of
natural regulatory T cells in human peripheral blood [35]. Thus,
our results indicate that patients with either Behcet’s disease or
Sarcoidosis have low frequency of peripheral natural regulatory T
cells and, therefore, potentially compromised immunoregulatory
functions during inflammatory responses.
In order to separate Behc¸et’s disease and sarcoidosis, predictions
based on all cells are very poor (Fig. 3(d)), better for CD4+ T cells
(Fig. 3(e)) and best for CD8+ T cells (Fig. 3(f)), for which no failed
predictions are made when five or more measures are used. This
result indicates that the top measures listed in Fig. 3(f) may be used
as molecular phenotypes that distinguish the two diseases. This is,
to the best of our knowledge, the first report pointing out that
CD8+ T cells can be used to distinguish two systemic inflammatory
diseases. Moreover, it is interesting to note that, in distinguishing
between patients with ocular inflammation and controls without it,
the CD4 marker was an important feature, while for distinguishing
between the ocular manifestations of two systemic disorders, the
CD8 cell marker was superior.
Given our success in demonstrating the power of molecular
phenotyping to distinguish the diseases, we turn now to the analysis
of the balance between the number of cells we need to average, and
the number of molecular markers we need to measure. For the
‘‘healthy vs diseased’’ case using CD4+ T cells, the percentage of
correctly classified supercells is shown in Fig. 3(g) as a function of the
supercell size and the number of measures used. Note that for single
cells, the classification performance is very poor even using many
measures, but averaging over more than ten cells is sufficient for
reliable classification if a large number of measures is used. In
contrast, just one measured marker is sufficient provided that we
average over 100+ cells. This fact is underscored in Fig. 3(h), where
the intensity distribution for supercells of size 500 are shown
separately for the healthy and the diseased patients, using just the
top marker (CD27). The dashed line indicates the marker intensity
threshold that allows a complete separation of the two classes of
supercells. The ‘‘sarcoidosis vs Behc¸et’s’’ classification is further
studied in Fig. 3(i) for CD8+ T cells, where the percentage of
correctly classified supercells is shown as a function of the supercell
size and the number of measures used. We find that slightly less than
100 cells are sufficient for reliable classification, as long as the top
five markers are measured. Increasing the number of markers or
averaging over more cells does not strongly change the reliability of
the classification. Finally, the ability to classify Behc¸et’s disease vs
sarcoidosis when using the top 5 markers is visualized in a new way
From Cellular Characteristics to Disease Diagnosis
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in Fig. 3(j). The visualization is derived from the identification of
patterns in two-dimensional parameter space (Fig. 1A(i)), which has
proven to be a tremendously successful tool for the analysis of low-
dimensional data in flow cytometry. The combined approach of cell
averaging into supercells, followed by machine learning, allows us to
find the correct linear combinations of markers needed to fully
separate the two diseases (Fig. 3(j)). In geometrical terms, we learned
that only 5 dimensions (out of the original 16) are needed; moreover,
we determined the preferred direction that maximizes the gradient
between the ‘‘sarcoidosis class’’ and the ‘‘Behc¸et’s disease class’’.
This optimal class separation was achieved by means of an
unbiased, mathematically robust method: no additional biological
information was needed to proceed from Fig. 1A(i) to Fig. 3(j).
Discussion
We present a simple approach to quantify disease phenotypes
based on single cell measurements with multiple parameters
measured on each cell. For our study of autoimmune diseases, we
measure 16 parameters for millions of cells with flow cytometry, and
use this information to find a molecular phenotype of Behc¸et’s
disease. We also measure 15 parameters from hundreds of
fluorescence images obtained via microscopy, and use this
information to automate classification of HGPS. Our data span
many more dimensions than the traditional two parameters used for
visually-aided cell classification (Fig. 1A). We use machine learning,
which allows for a reproducible, objective, and automated approach
to find the optimal boundary between two high- dimensional classes
of data points. The question we tackle is straightforward: do we
obtain more information about a disease by the analysis of more
cells, or by measuring more parameters on each cell?
The key to our novel approach is to introduce variable size cell
groups (‘‘supercells’’), with the group size as an explicit parameter
that we vary systematically. This reveals the number of cells that
need to be grouped in order to obtain a robust disease
classification. We also determine to what degree adding param-
Figure 4. Summary of the supercell approach. (a) 2D synthetic data representing 7 single-cell patient samples in two categories. Due to cell
heterogeneity, different phenotypes overlap and the data are non-separable. (b) A machine learning approach such as support vector machines is
able to find the optimal decision boundary between two classes of datapoints. However, this method (and variants thereof) fail when the samples are
strongly overlapping, as is the usual case for single-cell datasets (recall Fig. 1A(i)). (c) Sample means or higher-order moments of the cell multivariate
distributions generally lead to poor, non-robust phenotypes. The solid line is the class boundary learnt using all datapoints; by removing either of the
support vectors that define this boundary (marked by ‘‘I’’, ‘‘II’’, and ‘‘III’’), the boundary changes as indicated by the dashed lines, thus leading to
jackknife prediction failures. (d) Representing patient samples by supercell distributions, class separation becomes robust. Removing patient samples
‘‘I’’, ‘‘II’’, or ‘‘III’’, the decision boundary changes as shown by the dashed lines. Departures from the boundary learnt using all patients (solid line) are
less significant and do not cause any jackknife failed predictions.
doi:10.1371/journal.pcbi.1003215.g004
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eters reduces the number of cells needed to determine a
phenotype.
Our approach to separate cell groups relies on a machine
learning classification method. It is tailored specifically to
determine the most useful combination of parameters to distin-
guish among all cells or cell groups rather than finding the optimal
low-dimensional representation, as in singular value decomposi-
tion or principal component analysis. This procedure is schemat-
ically illustrated in Fig. 4, where synthetic 2D datasets were
generated to represent patient samples classified in two categories:
4 samples correspond to ‘‘Class A’’, while the remaining 3 samples
are labeled ‘‘Class B’’. At the single-cell level, the data are non-
separable due to cell heterogeneity (Fig. 4(a)). A machine learning
classifier such as support vector machines with a linear kernel
(Fig. 4(b)) can be implemented in order to find the optimal decision
boundary between the two classes; however, this method requires
the data to be separable. More sophisticated variants, such as soft
margin classifiers and nonlinear classifiers can be designed to learn
from non-separable data, even in strongly overlapping cases such
as those usually encountered in single-cell datasets (see e.g.
Fig. 1A(i)). However, our analysis shows that the optimal
‘‘boundary’’ inferred from overlapping distributions is distinct
from the boundary obtained from supercells which actually has
predictive power for phenotyping: the weight of parameters is very
different for single cells and supercells whose distribution is well
separated. In order to avoid overlapping patient samples, one
could characterize each of them by the moments of the cell
multivariate distributions, the simplest example being the sample
means (Fig. 4(c)). This approach, however, lacks robustness: the
decision boundaries are very sensitive to nearby datapoints, in
particular to the support vectors that determine the classification
hyperplanes, thus leading to failed predictions. Supercell distribu-
tions are built by averaging over groups of single cells. By applying
machine learning on supercell samples, a robust class separation is
achieved (Fig. 4(d)).
In HGPS, our approach confirms the current practice that the
number of invaginations (or mean negative curvature) is the most
valuable nuclear metrics for phenotyping the disease using nuclear
images. Importantly, we find that when analyzing 30 cells or more,
a robust phenotype can be obtained simply based on the
invaginations of each cell, and a more in depth analysis of
additional nuclear shape metrics does not significantly reduce the
number of cells needed. Our findings provide a principle guideline
of the minimal cell numbers used in future disease assessments and
high-throughput drug screenings of age-related diseases, in which
abnormal nuclear shape is considered a hallmark phenotype. This
information is of extreme importance in a rare disease like HGPS
with very limited availability of patient samples.
In our second example, we apply our technique to distinguish
healthy individuals from patients with two non-infectious uveitides,
and among those patients we distinguish between Behc¸et’s disease
and sarcoidosis. In order to distinguish healthy from disease
phenotypes, we found that within the CD4+ T cell subpopulation,
just one marker was enough (Fig. 3(b)). Indeed, CD27 appears
consistently overexpressed in healthy samples (Fig. 3(h)). The
ability to predict healthy and diseased phenotypes based on CD4+
T (super)cells is resilient under the removal of the top markers:
even by removing the top 7 markers from the list, we are still able
to classify patients as healthy or diseased with no failures. In
contrast, CD8+ T cells do not have a clear distinction between
healthy and diseased conditions, even using all markers available
from the flow cytometry experiment (Fig. 3 (c)). However, by
focusing specifically on sarcoidosis and Behc¸et’s disease, we
demonstrate a robust means of predicting a patient’s diagnosis
based on 5 optimally chosen markers using CD8+ T (super)cells
(Fig. 3(f)). If the top marker (IL22) is removed from the list,
incorrect predictions are observed even using all remaining
markers; therefore, phenotyping sarcoidosis vs Behc¸et’s is inher-
ently high-dimensional (since it requires at least 5 markers to be
accurate) and also very specific to those markers. An important
evaluation for the future will be to evaluate the efficacy of these
markers in patients with these two systemic disorders who do not
have ocular complications of their disease, i.e. whether these
findings are specific to the ocular disorder, or a reflection of the
systemic disorder itself. By using a precise linear combination of
IL22, CD3, viability, CD8 and CD62L, we are able to separate
the two diseases successfully based on molecular markers (Fig. 3(j)).
Averages of hundreds of cells are required for this phenotyping,
and increasing the number of measured parameters does not
reduce the number of cells required. The molecular markers used
have been reported to be important players in autoimmune
disorders. Yang et al. [36] reported an increased number of Th22
cells and increased serum IL-22 levels in patients with lupus skin
disease, but a decrease in patients with lupus nephritis. CD62L has
been reported to be associated with CD4+CD25brightFOXP3+ cells
in bullous pemphigoid patients [37]. Finally, expanded clones of
CD8+ T lymphocytes are present in the lesions of multiple sclerosis
[38]. Based on the observations from the analyses presented here,
our evaluation of CD8+ T cells has permitted us to see CD8-subset
differences in this cell type in patients diagnosed with different
uveitides.
Our ability to study the tradeoff between measuring more
parameters or analyzing more cells, as shown in Figs. 3(g) and 3(i),
has far-reaching consequences for a number of emerging
technologies that allow for multi-parameter single-cell measure-
ments. For more challenging problems than those considered here,
it may become necessary to study the distributions of the
measurement vectors of individual cells rather than its principal
surrogate of the first moment, and extend the machine learning
algorithms to well-chosen non-linear kernels. High-throughput
automated microscopy, where thousands of cells are imaged
automatically, is quickly becoming the norm, calling for reliable
approaches to classify observations and quantify phenotypes.
Similarly, while simultaneous (multicolor) measurement of 16
parameters is the current state-of-the-art for flow cytometry, a next
generation of high-throughput single-cell analysis tools is emerging
that will allow the measurement of more than 50 parameters at
comparable high throughput by means of mass cytometry [3,4]. It
is now also becoming possible to analyze gene sequences or gene
expression levels for individual cells, although the cost of these
expensive technologies severely limits the sample size to much
fewer cells than flow cytometry [5,6]. Optimizing the tradeoff
between measuring more cells or more parameters, as we
demonstrate here, should allow us to take full advantage of these
powerful and promising next-generation single-cell technologies.
Methods
Ethics Statement
This investigation was conducted according to the principles
expressed in the Declaration of Helsinki and was approved by
institutional review boards at National Eye Institute, National
Institutes of Health. The written informed consent was provided
by all patients.
For the study of Hutchinson-Gilford progeria syndrome,
cultured fibroblasts from two patients (HGADFN164-p15 and
HGADFN167-p15) and two healthy individuals (HGADFN090-
p15 and HGADFN168-p15) were used. The cells were fed with
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fresh MEM medium containing 15% FBS and grown at 37uC. In
order to visualize the nuclei, we performed immunofluorescence
staining of the nuclear membrane with a mouse monoclonal
antibody raised against lamin A/C. (MAB3211). This antibody
has been well characterized in HGPS cells and has also been used
in studies of other laminopathies. Fluorescence images of about
600 nuclei per cell line were taken with a Zeiss fluorescence
microscope at 4006magnification, as shown in the examples from
Figure 1B. Following the procedure from Driscoll et al (15), a
custom-written MATLAB program was used to extract nuclear
shapes and their properties, such as the number of invaginations,
the mean curvature, the standard deviation of the curvature, etc.
In addition to 12 shape measurements, we obtained 3 measure-
ments of the intensity of immunofluorescence from lamin A/C
associated with each nucleus (the full list of measurements is
provided in Figure 2C(i).
For the study of non-infectious uveitides, peripheral blood
samples were obtained from a cohort of 22 patients, out of which
7 were diagnosed with sarcoidosis, 6 with Behc¸et’s disease, 1 with
retinal vasculitis, while the remaining 8 were healthy controls. 3
different marker panels were studied on each sample, each consisting
of 2 scattering measurements (FSC and SSC) plus 14 or 15 cell
surface fluorochromes. Some common markers (such as CD3, CD4,
CD8, CD27, CD45, and viability) were used on all 3 panels and
were checked for consistency. Separate analyses have been
performed on each set of markers in order to find the best prediction
accuracy. Two marker panels did not lead to accurate sarcoidosis vs
Behc¸et’s disease phenotypes; the third one, which led to an accurate
phenotype and has been discussed throughout, consisted of FSC,
SSC, IL23R, CD196, CD4, viability, CD8, CD27, CD45, IL17A,
CD197, CD3, IL22, CD62L, CD161, and TNFA.
Pre-processed datasets are provided as Supporting Information.
Multicolor flow cytometry raw datasets are available at the Dryad
Repository: http://dx.doi.org/10.5061/dryad.v6st3.
Data analysis was performed using custom-written programs in
R and Perl.
Supporting Information
Dataset S1 Nuclear shape and lamin A/C measurements for 2
healthy and 2 HGPS cell lines.
(XLS)
Dataset S2 Multicolor flow cytometry (all cells) from 22 patients
labeled according to disease type or healthy status for a
randomized single-cell subsample and for the different supercell
sizes used in this paper.
(XLS)
Dataset S3 Multicolor flow cytometry (CD4+ T cells) from 22
patients labeled according to disease type or healthy status for a
randomized single-cell subsample and for the different supercell
sizes used in this paper.
(XLS)
Dataset S4 Multicolor flow cytometry (CD8+ T cells) from 22
patients labeled according to disease type or healthy status for a
randomized single-cell subsample and for the different supercell
sizes used in this paper.
(XLS)
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